Performance at Month End

Merrill Lynch Greater Europe IT PLC 17 May 2005 MERRILL LYNCH GREATER EUROPE INVESTMENT TRUST plc All information is at 30 April 2005 and unaudited. Performance at month end with net income reinvested One Three Since launch Month Months (20Sep04) Net asset value -3.9% -1.8% 9.4% Share price -3.2% -0.2% 5.5% FTSE World Europe ex UK -4.1% -1.9% 7.9% Sources: Merrill Lynch Investment Managers and Datastream. At month end Net asset value: 109.45p Includes net revenue of 1.01p Share price: 105.50p Discount to NAV: 3.6% Gearing: 3.6% Net yield: N/A Total assets: £185.1m Ordinary shares in issue: 164,841,285 Benchmark Sector Analysis Total Assets (%) Index (%) Country Analysis Total Assets (%) Financials 33.8 30.5 France 26.0 Cyclical Services 10.4 6.2 Germany 16.7 Non Cyclical Consumer Goods 11.4 15.7 Switzerland 14.4 Resources 9.5 9.6 Scandinavia 7.6 Basic Industries 7.3 7.1 Italy 7.4 Non Cyclical Services 5.9 1.3 Sweden 4.9 Utilities 4.9 6.5 Spain 3.7 Telecoms 4.6 8.2 Russia 3.5 Capital Goods 4.2 5.5 Ireland 3.2 Cyclical Consumer Goods 3.2 4.5 Belgium 2.8 Technology 2.8 4.9 Netherlands 2.4 Other Investments 2.4 - Israel 2.3 Net Current Liabilities (0.4) - Turkey 1.9 Greece 1.6 Portugal 0.9 Poland 0.9 Other Countries 0.2 Net Current Liabilities (0.4) ----- ----- ----- 100.0 100.0 100.0 ----- ----- ----- Ten Largest Equity Investments Company % of Total Assets Country of Risk Total 4.6 France Sanofi-Aventis 3.4 France UBS 3.4 Switzerland Roche Holdings 2.7 Switzerland Capitalia 2.5 Italy Ericsson 2.5 Sweden AXA 2.5 France Credit Suisse 2.4 Switzerland Societe Generale 2.4 France Carrefour 2.2 France ---- Total 28.6 ---- Commenting on the markets, James Macmillan, representing the Investment Manager noted: Equity markets declined for a second consecutive month in April 2005 with the FTSE World Europe ex UK and MSCI Emerging Europe down 4.1% and 3.4% in sterling terms respectively. Whilst investors were encouraged by the retreating oil price, there was considerable concern about evidence of sharply decelerating global economic growth. Another widely anticipated 0.25% increase in US short term interest rates (pencilled in for early May) did little to alter the market expectation of further monetary tightening in the US. The Company's NAV returned -3.9% during the month, outperforming the reference benchmark index. During the month stock selection was slightly positive with sector selection having a negative effect on performance. The Company benefited from exposure to Emerging Europe, with a number of holdings in Israel, Russia and Turkey outperforming. In light of a rising uncertainty the more defensive segments of the market did best in April with Pharmaceuticals (+4%), Real Estate (+2%), Tobacco (+1%), Other Utilities (+1%), Health (-2%) and Electricity (-2%) all posting above average returns. Against the trend IT Hardware stocks also 'outperformed' (-1%) following a run of poor performance in previous months. Most cyclical sectors did poorly with Steel (-12%), Leisure & Hotels (-9%), Electronic & Electrical Equipment (-9%), Forestry & Paper (-8%), Household Goods & Textiles (-7%) and Engineering & Machinery (-7%) clearly underperforming. The Life Assurance (-7%) and Insurance (-7%) sectors also suffered because of their perceived exposure to equity markets. During the period the best performing stocks were Capitalia which rose after good results and bid speculation within the Italian banking sector, Roche up after positive news flow on its key cancer drug, and Fortum which rose ahead of the IPO of its oil refining business Neste Oil. Other strong performers were Emporiki Bank of Greece, Sanofi-Aventis and Statoil. Stocks that detracted from performance were engineering consultant Altran Technologies down after the company missed second half margin targets, Prokom Software due to corporate governance issues, and steel producer Arcelor due to concerns that the steel cycle may have peaked. Other poor performers were car manufacturer Porsche, Ahold and and Kuoni. During March the Company purchased holdings in Swiss Investment bank Credit Suisse, Healthcare company Fresenius and spirits producer Pernod Ricard. This was partly funded by reducing exposure to the IT sector by selling Nokia and Altran Technologies. The main bias of the Company is towards financials and defensives at the expense of cyclicals and growth. This is reflected at the sector level through banks, diversified financials, energy, telecoms and pharmaceuticals. The main country exposures are in France, Germany and Switzerland. Our exposure to Emerging Europe was 10.1% and the Trust ended the month with a net market exposure of 103.6%. The macroeconomic newsflow was generally soft in April. Recent surveys suggest that business confidence has faltered in Continental Europe as a result of high energy prices and a weak US Dollar. Despite some bright spots in the periphery countries such as Spain and Ireland, domestic demand across much of Continental Europe continues to be weak as households suffer from persistently high unemployment and weak purchasing power. GDP growth in the Eurozone was reported to have run at 0.5% quarter on quarter in Q1 with little improvement in prospect. The consensus view is that economic growth will remain below its potential rate for the foreseeable future. As a result few observers expect the European Central Bank to raise interest rates any time soon. Latest information is available by typing www.mlim.co.uk/its on the internet, 'MLIMINDEX' on Reuters, 'MLIM' on Bloomberg or '8800' on Topic 3 (ICV terminal). 17 May 2005 This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings